References
Furusho K, Nakano H, Shinomiya K, Tamura T, Manabe Y, Kawarano M, Baba K, Kamiya T, Kiyosawa H, Hayashiedera T, Hirose O, Yokoyama T, Baba K, Mori C (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1055–1058
Huret JL, Delabar JM, Marlhens F, Aurias A, Nicole A, Berthier M, Tanzer J, Sinet PM (1987) Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality. Hum Genet 75:251–257
Imbach P, D'Appuzo V, Hirt A, Rossi E, Vest M, Baradun S, Baumgartner C, Morell A, Schoni M, Wagner HP (1981) High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet II:1228–1231
Mc Emery G, Nash FW (1973) Wiskott Aldrich syndrome associated with idiopathic cortical hyperostosis. Arch Dis Child 48:818–821
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berthier, M., Bonneau, D. & Huret, J.L. Caffey disease responding to high-dose immunoglobulin. Eur J Pediatr 147, 443–444 (1988). https://doi.org/10.1007/BF00496434
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00496434